The listening session, held on the FDA’s White Oak Campus, featured 17 speakers representing patient groups, drug companies, ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental ...

The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with ...

For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might ...

A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country ...

Due to a significant gender gap, far less is known about the health risks of early or late puberty onset among boys than ...

A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using ...

Medicaid leaders and advocates say they’re shocked by the Trump administration’s harsh directives for implementing Medicaid ...

This is not a partisan issue, this is not a political issue.” — Isabella Cueto The U.S. has the strongest military in the ...

A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow.

Eli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a ...